Skip to main content
. Author manuscript; available in PMC: 2016 Jan 19.
Published in final edited form as: Am J Addict. 2013 Jul-Aug;22(4):344–351. doi: 10.1111/j.1521-0391.2013.12044.x

Table 1.

Descriptive Characteristics

Variable N Values
Age
Mean 91 39.37
Standard Deviation ± 11.29
Range 20–62

Stable Methadone Blocking Dose
Mean 85* 111.98mg/day
Standard Deviation ± 60.80
Range 20–330

Weeks to Stabilization
Mean 91 11.01
Standard Deviation ± 9.38
Range 1–56**

Variable N Percentage

Gender
Female 55 60.4%
Male 36 39.6%

Race/Ethnicity
African America 12 13.5%
Caucasian 70 78.7%
Hispanic 6 6.7%
Other 1 1.1%

Opiate Route of Administration
Intravenous 67.8 %
Oral 91 50%
Intranasal 49.4%
Combination of ≥ 2 of the Above 38.9%

History of Illicit Drug Use: Lifetime+
Marijuana 91 71.5%
Stimulants 64.8%
Benzodiazepines 70.3%
Combination of ≥ 2 of the Above 80.2%

History of Illicit Drug Use: Recent+
Marijuana 42%++
Stimulants 91 39.3%
Benzodiazepines 51.7%
Combination of ≥ 2 of the Above 46.6%
*

6 individuals did not stabilize within the initial 9 month period

**

only data from those that stabilized within the initial 9 month period were considered.

values do not sum to 100% due to poly-drug use.

+

in addition to opiates

++

values may be biased by purposeful sampling for cannabis use while in treatment.